Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

SANTYL

COLLAGENASE

Standard Dose
250U/GRAM
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary

Approval overview SANTYL is listed in Drugs@FDA under application 101995 (BLA).

Review priority: UNKNOWN Marketing status: Prescription Active ingredient COLLAGENASE Form and strength OINTMENT;TOPICAL - 250U/GRAM Sponsor SMITH AND NEPHEW Submission history Latest submission status date: 1965-06-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview SANTYL is listed in Drugs@FDA under application 101995 (BLA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient COLLAGENASE Form and strength OINTMENT;TOPICAL - 250U/GRAM Sponsor SMITH AND NEPHEW Submission history Latest submission status date: 1965-06-04 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: UNKNOWN

Interaction Notes

  • No interaction notes stored yet.